Global Active Pharmaceutical Ingredient Market | CAGR 6.07%

The Global Active Pharmaceutical Ingredient Market to grow from USD 171,302.56 Million in 2018 to USD 258,771.56 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.07%. Some of the major market players include Boehringer Ingelheim, Bristol-Myers Squibb, Novartis AG, Pfizer, Inc., and Sanofi.

360iResearch Logo
Global Active Pharmaceutical Ingredient Market | CAGR 6.07%
Report Code: PH-2AA0F85 | Publishing Date: February 2020 | Number of Pages: 101
Global Active Pharmaceutical Ingredient Market | CAGR 6.07%

Company Usability Profiles:

The global active pharmaceutical ingredient market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global active pharmaceutical ingredient market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Abbvie Inc.
  • Astrazeneca
  • Aurobindo Pharma
  • BASF SE
  • ELI Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Active Pharmaceutical Ingredient Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY TYPE
    • Generic Active Pharmaceutical Ingredients
    • Innovative Active Pharmaceutical Ingredients
  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MANUFACTURER
    • Captive API Manufacturers
    • Merchant API Manufacturers
      • Merchant Biotech API Manufacturers
      • Merchant Generic API Manufacturers
      • Merchant Innovative API Manufacturers
      • Merchant Synthetic API Manufacturers
  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNTHESIS
    • Biotech Active Pharmaceutical Ingredients
    • Synthetic Active Pharmaceutical Ingredients
  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC APPLICATION
    • Cardiovascular Diseases
    • Communicable Diseases
    • Diabetes
    • Oncology
    • Pain Management
    • Respiratory Diseases
  • GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • South Korea
      • Thailand
    • Europe, Middle East & Africa
      • Denmark
      • France
      • Germany
      • Italy
      • Netherlands
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • United Arab Emirates
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Active Pharmaceutical Ingredient Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Active Pharmaceutical Ingredient Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Active Pharmaceutical Ingredient Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Active Pharmaceutical Ingredient Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Active Pharmaceutical Ingredient Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Active Pharmaceutical Ingredient Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Active Pharmaceutical Ingredient Market .
  • Evaluate the key vendors in the Global Active Pharmaceutical Ingredient Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Market Data Feed
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increasing incidences of chronic diseases
        2. Growing importance of generics coupled with uptakes of biopharmaceuticals
        3. Technological advancements in active pharmaceutical ingredients
        4. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
        5. Rising focus on precision medicine and growing investment
      2. Restraints
        1. Unsupportive price control policies for drug across various countries
        2. Increasing availability of counterfeit drugs
      3. Opportunities
        1. Emergence of biosimilars
        2. Highly effective active pharmaceutical ingredients
      4. Challenges
        1. High cost associated with the manufacturing process
        2. Concern associated with the product differentiation
    3. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Client Customizations
      1. Market Ecosystem
  5. Global Active Pharmaceutical Ingredient Market, by Type
    1. Overview
    2. Market Sizing & Forecasting
    3. Generic Active Pharmaceutical Ingredients
    4. Innovative Active Pharmaceutical Ingredients
  6. Global Active Pharmaceutical Ingredient Market, by Manufacturer
    1. Overview
    2. Market Sizing & Forecasting
    3. Captive API Manufacturers
    4. Merchant API Manufacturers
      1. Merchant Biotech API Manufacturers
      2. Merchant Generic API Manufacturers
      3. Merchant Innovative API Manufacturers
      4. Merchant Synthetic API Manufacturers
  7. Global Active Pharmaceutical Ingredient Market, by Synthesis
    1. Overview
    2. Market Sizing & Forecasting
    3. Biotech Active Pharmaceutical Ingredients
    4. Synthetic Active Pharmaceutical Ingredients
  8. Global Active Pharmaceutical Ingredient Market, by Therapeutic Application
    1. Overview
    2. Market Sizing & Forecasting
    3. Cardiovascular Diseases
    4. Communicable Diseases
    5. Diabetes
    6. Oncology
    7. Pain Management
    8. Respiratory Diseases
  9. Global Active Pharmaceutical Ingredient Market, by Geography
    1. Overview
    2. Market Sizing & Forecasting
    3. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Chile
      5. Mexico
      6. United States
    4. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    5. Europe, Middle East & Africa
      1. Denmark
      2. France
      3. Germany
      4. Italy
      5. Netherlands
      6. Qatar
      7. Russia
      8. Saudi Arabia
      9. South Africa
      10. Spain
      11. United Arab Emirates
      12. United Kingdom
  10. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
        1. Forefront
        2. Pathfinders
        3. Niche
        4. Vital
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  11. Company Usability Profiles
    1. Boehringer Ingelheim
      1. Overview
      2. Strategy
      3. SWOT
    2. Bristol-Myers Squibb
      1. Overview
      2. Strategy
      3. SWOT
    3. Novartis AG
      1. Overview
      2. Strategy
      3. SWOT
    4. Pfizer, Inc.
      1. Overview
      2. Strategy
      3. SWOT
    5. Sanofi
      1. Overview
      2. Strategy
      3. SWOT
    6. Abbvie Inc.
    7. Astrazeneca
    8. Aurobindo Pharma
    9. BASF SE
    10. ELI Lilly and Company
    11. F. Hoffmann-La Roche
    12. Glaxosmithkline PLC
    13. Merck & Co., Inc.
    14. Sun Pharmaceutical Industries Ltd
    15. Teva Pharmaceutical Industries Ltd
  12. Appendix
    1. Discussion Guide
    2. Author Details

List of Tables

  1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT BIOTECH API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT GENERIC API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT INNOVATIVE API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MERCHANT SYNTHETIC API MANUFACTURERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  17. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY COMMUNICABLE DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  19. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  20. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  21. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  22. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY RESPIRATORY DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  23. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  24. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  25. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  26. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  27. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  28. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  29. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  30. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  31. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  32. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  33. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  34. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  35. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  36. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  37. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  38. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  39. CANADA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  40. CHILE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  41. CHILE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  42. CHILE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  43. CHILE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  44. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  45. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  46. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  47. MEXICO ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  48. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  49. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  50. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  51. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  52. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  53. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  54. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  55. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  56. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  57. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  58. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  59. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  60. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  61. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  62. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  63. CHINA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  64. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  65. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  66. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  67. INDIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  68. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  69. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  70. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  71. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  72. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  73. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  74. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  75. JAPAN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  76. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  77. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  78. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  79. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  80. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  81. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  82. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  83. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  84. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  85. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  86. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  87. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  88. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  89. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  90. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  91. THAILAND ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  92. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  93. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  94. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  95. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  96. DENMARK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  97. DENMARK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  98. DENMARK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  99. DENMARK ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  100. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  101. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  102. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  103. FRANCE ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  104. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  105. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  106. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  107. GERMANY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  108. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  109. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  110. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  111. ITALY ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  112. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  113. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  114. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  115. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  116. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  117. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  118. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  119. QATAR ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  120. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  121. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  122. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  123. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  124. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  125. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  126. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  127. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  128. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  129. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  130. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  131. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  132. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  133. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  134. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  135. SPAIN ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  136. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  137. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  138. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  139. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  140. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  141. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2016-2025 (USD MILLION)
  142. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2016-2025 (USD MILLION)
  143. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2016-2025 (USD MILLION)
  144. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RANKING
  145. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: AUTHOR DETAILS

List of Figures

  1. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RESEARCH PROCESS
  2. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: RESEARCH FRAMEWORK
  3. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FORECASTING METHODOLOGY
  4. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET CONNECTIVITY
  6. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: MARKET DYNAMICS
  7. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: PORTERS FIVE FORCES ANALYSIS
  8. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2018 VS 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY TYPE, 2025 (USD MILLION)
  10. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2018 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY MANUFACTURER, 2025 (USD MILLION)
  12. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2018 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY SYNTHESIS, 2025 (USD MILLION)
  14. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018 VS 2025 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 (USD MILLION)
  16. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  18. GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET: FPNV POSITIONING MATRIX
  19. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY NEWS TYPE
  20. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY COMPANY
  21. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY YEAR
  1. Boehringer Ingelheim
  2. Bristol-Myers Squibb
  3. Novartis AG
  4. Pfizer, Inc.
  5. Sanofi
  6. Abbvie Inc.
  7. Astrazeneca
  8. Aurobindo Pharma
  9. BASF SE
  10. ELI Lilly and Company
  11. F. Hoffmann-La Roche
  12. Glaxosmithkline PLC
  13. Merck & Co., Inc.
  14. Sun Pharmaceutical Industries Ltd
  15. Teva Pharmaceutical Industries Ltd
Global Active Pharmaceutical Ingredient Market
Report Code
PH-2AA0F85
Publishing Date
February 2020
Number of Pages
101
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $5449
CORPORATE USER LICENSE $4449
SINGLE USER LICENSE $3449
WEB PACK LICENSE $2949
DATA PACK LICENSE $1749

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.